Vaxart ( (VXRT) ) has released its Q3 earnings. Here is a breakdown of the information Vaxart presented to its investors. Vaxart, Inc. is a ...

With innovative clinical research services and custom-tailored solutions, Ergomed ensures that oncology treatments progress ...

Continuous research has led to new drug developments ... Sclerosis Pipeline Report The multiple sclerosis pipeline report ...

H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report) today and set a price target ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

Research Program: Cytokine reduction, ABX-002, Arsenic trioxide, LL-341070, PB018, FTX 101, TI-235, TRE 515, NT-0007, NT-0002, NVG300, and others are under different phases of multiple sclerosis ...

Research Program: Nitric Oxide Formulation, AROMUC 5AC, Lonodelestat, AZD-0292, CSL 787, Inhaled Murepavadin, NM001, SPL 5AC, Mucolytic Agents, and others are under different phases of non-cystic ...

With a bachelor's degree in nursing, you can pursue a wide variety of paths, from bedside care to corporate roles.

The Children’s Inn at NIH, a private nonprofit that supports kids in clinical trials, just broke ground on a long-planned ...

Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, today announced that it has expanded its leadership team with the appointments of Jan ...

He highlighted that companies should plan for the long term, even during the early phases of development. Recognizing and ...

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase ...